UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma

Clinical case reports, 2021-01, Vol.9 (1), p.429-432

2021

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers

Cancer prevention research (Philadelphia, Pa.), 2019-12, Vol.12 (12), p.903-912

2019

Volltextzugriff (PDF)

782 TransCon TLR7/8 agonist induces sustained local and systemic immune activation in patients with solid tumors

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A879-A879

2023

Volltextzugriff (PDF)

Corrigendum to: Time to put it out – nurse-facilitated tobacco treatment in a comprehensive cancer center

Translational behavioral medicine, 2022-03, Vol.12 (3), p.498-498

2022

Volltextzugriff (PDF)

Time to put it out – nurse-facilitated tobacco treatment in a comprehensive cancer center

Translational behavioral medicine, 2021-09, Vol.11 (9), p.1726-1738

2021

Volltextzugriff (PDF)

Methylation Profiling of CpG Islands in Human Breast Cancer Cells

Human molecular genetics, 1999-03, Vol.8 (3), p.459-470

1999

Volltextzugriff (PDF)

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2019-03, Vol.7 (1), p.79-16, Article 79

2019

Volltextzugriff (PDF)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)

Cancer medicine (Malden, MA), 2019-06, Vol.8 (6), p.2730-2739

2019

Volltextzugriff (PDF)

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

Biomarker research, 2019-07, Vol.7 (1), p.14-11, Article 14

2019

Volltextzugriff (PDF)

High-specific-activity 131 iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma

Future oncology (London, England), 2021-04, Vol.17 (10), p.1131-1141

2021

Volltextzugriff (PDF)

High-specific-activity 131iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma

Future oncology (London, England), 2021-04, Vol.17 (10), p.1131-1141

2021

Volltextzugriff (PDF)

BTCRC-HN17-111, A phase 2 trial of ADT (goserelin) in combination with pembrolizumab for patients with advanced salivary gland tumors expressing androgen receptor (AR)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18091-e18091

2022

Volltextzugriff (PDF)

CpG Island Arrays: An Application toward Deciphering Epigenetic Signatures of Breast Cancer

Clinical cancer research, 2000-04, Vol.6 (4), p.1432-1438

2000

Volltextzugriff (PDF)

A phase Ib study of combination of avelumab and taxane-based chemotherapy in platinum refractory or ineligible metastatic urothelial cancer (AVETAX study)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.487-487

2020

Volltextzugriff (PDF)

CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS6089-TPS6089

2021

Volltextzugriff (PDF)

Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique

Cancer research (Chicago, Ill.), 1997-03, Vol.57 (6), p.1030-1034

1997

Volltextzugriff (PDF)

Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)

Cancer chemotherapy and pharmacology, 2014-10, Vol.74 (4), p.691-697

2014

Volltextzugriff (PDF)

Effects of GC4419 (avasopasem manganese) on chronic kidney disease in head and neck cancer patients treated with radiation and cisplatin

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.12071-12071

2020

Volltextzugriff (PDF)

Abstract CT098: Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT098-CT098

2018

Volltextzugriff (PDF)

Abstract LB180: Clinical biomarker studies with two fusion-enhanced versions of oncolytic HSV (RP1 and RP2) alone and in combination with nivolumab in cancer patients indicate potent immune activation

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB180-LB180

2021

Volltextzugriff (PDF)

Preliminary results of phase I clinical trial of high doses of seleno-L-methionine (SLM) in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.660-660

2019

Volltextzugriff (PDF)

An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e22050-e22050

2020

Volltextzugriff (PDF)

679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A770-A770

2023

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose and Steady State Pharmacokinetics Study of 9cUAB30 in Healthy Volunteers

Cancer prevention research (Philadelphia, Pa.), 2019-09, Vol.12 (12), p.903-912

2019

Volltextzugriff (PDF)

Retrospective comparison between high-dose cisplatin and less-intensive weekly cisplatin/paclitaxel concurrently with radiation for locally advanced head and neck cancer (LAHNC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e17535-e17535

2016

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(51)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose, and Steady-State Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers

782 TransCon TLR7/8 agonist induces sustained local and systemic immune activation in patients with solid tumors

Corrigendum to: Time to put it out – nurse-facilitated tobacco treatment in a comprehensive cancer center

Time to put it out – nurse-facilitated tobacco treatment in a comprehensive cancer center

Methylation Profiling of CpG Islands in Human Breast Cancer Cells

Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

High-specific-activity 131 iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma

High-specific-activity 131iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma

BTCRC-HN17-111, A phase 2 trial of ADT (goserelin) in combination with pembrolizumab for patients with advanced salivary gland tumors expressing androgen receptor (AR)

CpG Island Arrays: An Application toward Deciphering Epigenetic Signatures of Breast Cancer

A phase Ib study of combination of avelumab and taxane-based chemotherapy in platinum refractory or ineligible metastatic urothelial cancer (AVETAX study)

CMP-001-007: Open-label, phase 2 study of intratumoral CMP-001 + pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma

Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique

Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)

Effects of GC4419 (avasopasem manganese) on chronic kidney disease in head and neck cancer patients treated with radiation and cisplatin

Abstract CT098: Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC)

Abstract LB180: Clinical biomarker studies with two fusion-enhanced versions of oncolytic HSV (RP1 and RP2) alone and in combination with nivolumab in cancer patients indicate potent immune activation

Preliminary results of phase I clinical trial of high doses of seleno-L-methionine (SLM) in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients

An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts

679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study

A Randomized, Placebo-Controlled, Double-Blind, Dose Escalation, Single Dose and Steady State Pharmacokinetics Study of 9cUAB30 in Healthy Volunteers

Retrospective comparison between high-dose cisplatin and less-intensive weekly cisplatin/paclitaxel concurrently with radiation for locally advanced head and neck cancer (LAHNC)

Suchergebnisse filtern